Generics gain ground, yet HCPs still favor branded drugs, finds GlobalData
A significant proportion of healthcare professionals still tend to favor branded drugs
A significant proportion of healthcare professionals still tend to favor branded drugs
ABRYSVO met its trial primary endpoints in adults aged 18 to 59 with an increased respiratory syncytial virus (RSV) disease risk.
Total value of the supplies of FC will be US$ 2.773 million
Vericiguat works on a pathway not currently targeted by existing heart failure treatments
A game changing solution for the pharmaceutical industry
The company plans to add 1700 beds by FY27 through the organic route
International Business is expected to register double-digit growth in constant currency terms
Aurigene.AI is an end-to-end solution for small molecule drug discovery
Subscribe To Our Newsletter & Stay Updated